Globe Life Growth Cools Across Divisions Even as Profit Rises
Globe Life posted a 20% jump in diluted earnings per share to $3.65, but slowing health sales and a thinner underwriting margin at its largest division signaled the deceleration beneath the headline number.
Globe Life (GL) reported second-quarter net income of $3.65 a diluted share, up 20% from $3.05 a year earlier, while net operating income per share rose 10% to $3.61 from $3.27. The life and supplemental health insurer raised its full-year 2026 earnings guidance to a range of $15.55 to $15.95 a share, a midpoint increase of $0.10.
The growth rate itself told a different story than the headline figures. Net income per share grew 13% year over year in the first quarter of 2026 and 38% in the third quarter of 2025; the second-quarter pace of 20% and 10% net operating growth marked a clear deceleration from both prior periods. The guidance raise reflected the same pattern: the $0.10 midpoint increase this quarter followed a $0.35 midpoint increase in the first-quarter update.
Profitability metrics softened alongside the slower growth. Net income return on equity for the six months ended June 30 came in at 18.4%, down from 18.8% in the same period of 2025, while net operating ROE excluding accumulated other comprehensive income slipped to 14.3% from 14.4%. Book value per share rose 18% to $78.18, and book value excluding AOCI rose 11% to $100.04, both decelerating from 19% and 12% growth respectively in the first quarter.
Total premium revenue rose 7% to $1.30 billion, with health premium growing 16% to $436.9 million and life premium growing just 3% to $860.8 million. Health remained the faster-growing line, but the growth itself was slowing at the source: United American Division health premium grew 29% year over year, moderating from 22% growth in the first quarter, even as it stayed the company's fastest-growing segment. United American health net sales growth decelerated more sharply, to 10% from a near-doubling in the first quarter and from roughly $30 million to $77 million in the fourth quarter of 2025. The division's health underwriting margin fell 12% to $10.9 million, or 5% of premium, down from 8% a year earlier, reversing the margin gains reported in the first quarter.
The deceleration extended across other divisions. Family Heritage health net sales growth slowed to 4% from 22% in the first quarter and 15% in the fourth quarter of 2025, even as health premium growth held near 9% to 10%. Liberty National life net sales growth eased to 6% from 13% in the prior quarter. Direct to Consumer life net sales fell 15% to $26.6 million, reversing growth of 8% in the first quarter and 24% in the fourth quarter of 2025. American Income Life's average producing agent count declined 7% to 11,391, down from 11,064 in the first quarter, a reversal from flat-to-growing headcount trends elsewhere in the company.
Insurance underwriting income per share rose 10% to $4.69, a marked slowdown from the 39% surge reported in the third quarter of 2025, when a $134.3 million actuarial remeasurement gain inflated the comparison. Life underwriting margin growth decelerated to 6% from 24% in the third quarter of 2025, and health underwriting margin growth slowed even more sharply, to 1% from 25%. Excess investment income per share was a bright spot, rising 17% to $0.49 and accelerating from 10% growth in the first quarter, though still below the pace seen before a 16% decline in the fourth quarter of 2025.
Globe Life continued share repurchases, spending $175 million to buy back 1.1 million shares in the quarter, down from $203 million and 1.4 million shares in the first quarter and $226 million and 1.9 million shares a year earlier. The reduced buyback pace nonetheless cut weighted average diluted shares outstanding to 78.9 million from 82.8 million a year earlier, supporting per-share results even as underlying growth slowed. The administrative expense ratio improved slightly to 7.0% of premium from 7.1%.